皮膚科向けCRO(医薬品開発業務受託機関)の世界市場2022〜2032

◆英語タイトル:Dermatology CROs Market Report 2022-2032

visiongainが発行した調査報告書(VGA22DV012)◆商品コード:VGA22DV012
◆発行会社(リサーチ会社):visiongain
◆発行日:2022年11月23日
◆ページ数:237
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Sigle User(1名様閲覧用、1年間、印刷不可)GBP3,950 ⇒換算¥711,000見積依頼/購入/質問フォーム
Enterprise(法人閲覧用、1年間、印刷可)GBP6,950 ⇒換算¥1,251,000見積依頼/購入/質問フォーム
※visiongain社発行の調査レポートは、Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。

販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

ビジョンゲイン社の本調査レポートでは、世界の皮膚科向けCRO(医薬品開発業務受託機関)市場規模が、2032年までに年平均成長率8.7%で拡大すると予想しています。本レポートは、皮膚科向けCRO(医薬品開発業務受託機関)の世界市場を調査対象とし、レポート概要、エグゼクティブサマリー、市場概要、種類別(創薬、前臨床、臨床)分析、サービス別(プロジェクト管理、薬事・医療関連業務、臨床試験監視、品質管理・保証、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ、アメリカ、カナダ、ドイツ、イギリス、フランス、イタリア、日本、中国、インド、韓国、ブラジル、メキシコ、中東、南アフリカ、その他地域)分析、競争状況、企業情報、提言などの項目を掲載しております。また本レポートには、Biorasi, LLC、Bioskin 、ICON Plc、Innovaderm、IQVIA、Javara、LabCorp、PAREXEL International Corp、Proinnovera、Syneos Health, Inc.などの企業情報が含まれています。
・レポート概要
・エグゼクティブサマリー
・市場概要

・世界の皮膚科向けCRO(医薬品開発業務受託機関)市場規模:種類別
- 創薬における市場規模
- 前臨床における市場規模
- 臨床における市場規模

・世界の皮膚科向けCRO(医薬品開発業務受託機関)市場規模:サービス別
- プロジェクト管理における市場規模
- 薬事・医療関連業務における市場規模
- 臨床試験監視における市場規模
- 品質管理・保証における市場規模
- その他における市場規模

・世界の皮膚科向けCRO(医薬品開発業務受託機関)市場規模:地域別
- 北米の皮膚科向けCRO(医薬品開発業務受託機関)市場規模
アメリカの皮膚科向けCRO(医薬品開発業務受託機関)市場規模
カナダの皮膚科向けCRO(医薬品開発業務受託機関)市場規模

- ヨーロッパの皮膚科向けCRO(医薬品開発業務受託機関)市場規模
ドイツの皮膚科向けCRO(医薬品開発業務受託機関)市場規模
イギリスの皮膚科向けCRO(医薬品開発業務受託機関)市場規模
フランスの皮膚科向けCRO(医薬品開発業務受託機関)市場規模
イタリアの皮膚科向けCRO(医薬品開発業務受託機関)市場規模
その他地域の皮膚科向けCRO(医薬品開発業務受託機関)市場規模

- アジア太平洋の皮膚科向けCRO(医薬品開発業務受託機関)市場規模
日本の皮膚科向けCRO(医薬品開発業務受託機関)市場規模
中国の皮膚科向けCRO(医薬品開発業務受託機関)市場規模
インドの皮膚科向けCRO(医薬品開発業務受託機関)市場規模
韓国の皮膚科向けCRO(医薬品開発業務受託機関)市場規模

- 中南米の皮膚科向けCRO(医薬品開発業務受託機関)市場規模
ブラジルの皮膚科向けCRO(医薬品開発業務受託機関)市場規模
メキシコの皮膚科向けCRO(医薬品開発業務受託機関)市場規模

- 中東・アフリカの皮膚科向けCRO(医薬品開発業務受託機関)市場規模
中東の皮膚科向けCRO(医薬品開発業務受託機関)市場規模
南アフリカの皮膚科向けCRO(医薬品開発業務受託機関)市場規模

・競争状況
・企業情報
・提言

The Dermatology CROs Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or expand their existing operations in a new region.

Reduced market time, reduced infrastructure costs, and improved operational efficiency to drive the market growth
Reduced market time, infrastructure costs, and operational benefits are some of the major forces driving the dermatology CRO market. The expansion or localization of contract services by countries is expected to result in significant investments in facilities, equipment, and skilled labour. Furthermore, some countries with low resources are unable to manufacture vaccines due to a lack of equipment and experienced personnel. This causes the countries to create contracts with contract producers in order to meet the demands of the market.

Considering the COVID-19 pandemic, the contract outsourcing sector is well-positioned to respond too many of the challenges drug developers face. Several aspects of the drug company and biopharma industry have been affected by this pandemic, including drug development, clinical trials, supplies, manufacturing, and supply chain management. As a result of the pandemic, recruitment of trial participants has been complicated, while patients are also having difficulty enrolling in trials; these additional complications have led to longer, more expensive trials. A company known as Swift Medical, which develops digital wound care solutions, has introduced Swift Scientific, a new imaging platform designed to help clinical analysis companies conduct decentralized trials. The corporate has released it as its primary clinical trial product.

Patient recruitment challenges in dermatology clinical trials
In recruiting patients for dermatology clinical trials, irregular patient visits are one of the most challenging factors. Dermatological trials require regular site visits because skin changes can occur rapidly. Regular visits to the doctor have a significant impact on patients’ daily routines. A survey report reveals that lack of awareness pertaining to dermatology clinical trials, patient retention in the dermatology trials and scarcity of professionals recommending dermatology trials are some of the factors affecting the market growth.

What Questions Should You Ask before Buying a Market Research Report?
• How is the Dermatology CROs market evolving?
• What is driving and restraining the Dermatology CROs market?
• How will each Dermatology CROs submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each Dermatology CROs submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading Dermatology CROs markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the Dermatology CROs projects for these leading companies?
• How will the industry evolve during the period between 2022 and 2032? What are the implications of Dermatology CROs projects taking place now and over the next 10 years?
• Is there a greater need for product commercialization to further scale the Dermatology CROs market?
• Where is the Dermatology CROs market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Dermatology CROs market today, and over the next 10 years:
• Our 234-page report provides 88 tables and 117 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Dermatology CROs market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2032 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Dermatology CROs prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Type
• Drug Discovery
• Preclinical
• Clinical

Services
• Project Management/Clinical Supply Management
• Data Management
• Regulatory/Medical Affairs
• Medical Writing
• Clinical Monitoring
• Quality Management/ Assurance
• Bio-statistics
• Investigator Payments
• Laboratory
• Patient and site Recruitment
• Technology
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 18 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America Latin America

MEA
• GCC
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Dermatology CROs Market, 2022 to 2032, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Biorasi, LLC
• Bioskin
• Charles River Laboratories International, Inc.
• GVK Biosciences Private Limited
• ICON Plc
• Innovaderm
• IQVIA
• Javara
• Laboratory Corporation of America Holdings (LabCorp)
• Medidata Solutions, Inc.
• MEDPACE HOLDINGS, INC.
• PAREXEL International Corp
• Pharmaceutical Product Development, LLC (PPD)
• Pharmaron
• PRA Health Sciences
• Proinnovera
• Syneos Health, Inc.
• Wuxi AppTec

Overall world revenue for the Dermatology CROs Market, 2022 to 2032 in terms of value the market will surpass US$ 5,361 million in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Dermatology CROs Market, 2022 to 2032 report help you?
In summary, our 230+ page report provides you with the following knowledge:

• Revenue forecasts to 2032 for Dermatology CROs Market, 2022 to 2032 Market, with forecasts for type clinical, drug discovery, preclinical and services, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2032 for five regional and 18 key national markets – See forecasts for the Dermatology CROs Market, 2022 to 2032 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 10 of the major companies involved in the Dermatology CROs Market, 2022 to 2032.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Dermatology CROs Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.

❖ レポートの目次 ❖

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Dermatology CRO Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.2 Market Restraining Factors
3.2.3 Market Opportunities
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PESTLE Analysis

4 Global Dermatology CRO Market Analysis by Type
4.1 Key Findings
4.2 Type Segment Growth Prospects
4.3 Global Dermatology CRO Market Share by Type, 2022 & 2032
4.4 Drug Discovery
4.4.1 Drug Discovery Market Forecast by Region, 2022-2032 (US$ Mn)
4.4.2 Drug Discovery Market Share by Region, 2022-2032 (%)
4.5 Pre-clinical
4.5.1 Pre-clinical Market Forecast by Region, 2022-2032 (US$ Mn)
4.5.2 Pre-clinical Market Share by Region, 2022-2032 (%)
4.6 Clinical
4.6.1 Clinical Market Forecast by Region, 2022-2032 (US$ Mn)
4.6.2 Clinical Market Share by Region, 2022-2032 (%)

5 Global Dermatology CRO Market Analysis by Services
5.1 Key Findings
5.2 Services Segment Growth Prospects
5.3 Global Dermatology CRO Market Share by Services, 2022 & 2032
5.4 Project Management
5.4.1 Project Management Market Forecast by Region, 2022-2032 (US$ Mn)
5.4.2 Project Management Market Share by Region, 2022-2032 (%)
5.5 Data Management
5.5.1 Data Management Market Forecast by Region, 2022-2032 (US$ Mn)
5.5.2 Data Management Market Share by Region, 2022-2032 (%)
5.6 Regulatory/Medical Affairs
5.6.1 Regulatory/Medical Affairs Market Forecast by Region, 2022-2032 (US$ Mn)
5.6.2 Regulatory/Medical Affairs Market Share by Region, 2022-2032 (%)
5.7 Medical Writing
5.7.1 Medical Writing Market Forecast by Region, 2022-2032 (US$ Mn)
5.7.2 Medical Writing Market Share by Region, 2022-2032 (%)
5.8 Clinical Monitoring
5.8.1 Clinical Monitoring Market Forecast by Region, 2022-2032 (US$ Mn)
5.8.2 Clinical Monitoring Market Share by Region, 2022-2032 (%)
5.9 Quality Management/Assurance
5.9.1 Quality Management/Assurance Market Forecast by Region, 2022-2032 (US$ Mn)
5.9.2 Quality Management/Assurance Market Share by Region, 2022-2032 (%)
5.10 Bio-statistics
5.10.1 Bio-statistics Market Forecast by Region, 2022-2032 (US$ Mn)
5.10.2 Bio-statistics Market Share by Region, 2022-2032 (%)
5.11 Investigator Payments
5.11.1 Investigator Payments Market Forecast by Region, 2022-2032 (US$ Mn)
5.11.2 Investigator Payments Market Share by Region, 2022-2032 (%)
5.12 Laboratory
5.12.1 Laboratory Market Forecast by Region, 2022-2032 (US$ Mn)
5.12.2 Laboratory Market Share by Region, 2022-2032 (%)
5.13 Patient and Site Recruitment
5.13.1 Patient and Site Recruitment Market Forecast by Region, 2022-2032 (US$ Mn)
5.13.2 Patient and site Recruitment Market Share by Region, 2022-2032 (%)
5.14 Technology
5.14.1 Technology Market Forecast by Region, 2022-2032 (US$ Mn)
5.14.2 Technology Market Share by Region, 2022-2032 (%)
5.15 Others
5.15.1 Others Market Forecast by Region, 2022-2032 (US$ Mn)
5.15.2 Others Market Share by Region, 2022-2032 (%)

6 Global Dermatology CRO Market Analysis by Region
6.1 Key Findings
6.2 Regional Market Size Estimation and Forecast
6.3 COVID-19 Impact Analysis: Recovery Scenarios (V, U, W, L)
6.4 North America Dermatology CRO Market Analysis
6.4.1 Key Findings
6.4.2 North America Dermatology CRO Market Attractiveness Index
6.4.3 North America Dermatology CRO Market by Country, 2022, 2027 & 2032 (US$ mn)
6.4.4 North America Dermatology CRO Market Size Estimation and Forecast by Country
6.4.5 North America Dermatology CRO Market Size Estimation and Forecast by Type
6.4.6 North America Dermatology CRO Market Size Estimation and Forecast by Services
6.4.7 U.S.
6.4.8 Canada
6.5 Europe Dermatology CRO Market Analysis
6.5.1 Key Findings
6.5.2 Europe Dermatology CRO Market Attractiveness Index
6.5.3 Europe Dermatology CRO Market by Country, 2022, 2027 & 2032 (US$ mn)
6.5.4 Europe Dermatology CRO Market Size Estimation and Forecast by Country
6.5.5 Europe Dermatology CRO Market Size Estimation and Forecast by Type
6.5.6 Europe Dermatology CRO Market Size Estimation and Forecast by Services
6.5.7 UK
6.5.8 Germany
6.5.9 France
6.5.10 Italy
6.5.11 Spain
6.5.12 Russia
6.6 Asia Pacific Dermatology CRO Market Analysis
6.6.1 Key Findings
6.6.2 Asia Pacific Dermatology CRO Market Attractiveness Index
6.6.3 Asia Pacific Dermatology CRO Market by Country, 2022, 2027 & 2032 (US$ mn)
6.6.4 Asia Pacific Dermatology CRO Market Size Estimation and Forecast by Country
6.6.5 Asia Pacific Dermatology CRO Market Size Estimation and Forecast by Type
6.6.6 Asia Pacific Dermatology CRO Market Size Estimation and Forecast by Services
6.6.7 Japan
6.6.8 China
6.6.9 India
6.6.10 Australia
6.6.11 South Korea
6.7 Latin America Dermatology CRO Market Analysis
6.7.1 Key Findings
6.7.2 Latin America Dermatology CRO Market Attractiveness Index
6.7.3 Latin America Dermatology CRO Market by Country, 2022, 2027 & 2032 (US$ mn)
6.7.4 Latin America Dermatology CRO Market Size Estimation and Forecast by Country
6.7.5 Latin America Dermatology CRO Market Size Estimation and Forecast by Type
6.7.6 Latin America Dermatology CRO Market Size Estimation and Forecast by Services
6.7.7 Brazil
6.7.8 Mexico
6.8 MEA Dermatology CRO Market Analysis
6.8.1 Key Findings
6.8.2 MEA Dermatology CRO Market Attractiveness Index
6.8.3 MEA Dermatology CRO Market by Country, 2022, 2027 & 2032 (US$ mn)
6.8.4 MEA Dermatology CRO Market Size Estimation and Forecast by Country
6.8.5 MEA Dermatology CRO Market Size Estimation and Forecast by Type
6.8.6 MEA Dermatology CRO Market Size Estimation and Forecast by Services
6.8.7 GCC
6.8.8 South Africa

7 Competitive Landscape
7.1 Company Share Analysis
7.2 Strategic Outlook

8 Company Profiles
8.1 ICON Plc
8.1.1 Company Snapshot
8.1.2 Company Overview
8.1.3 Financial Analysis
8.1.4 Product Benchmarking
8.1.5 Strategic Outlook
8.2 IQVIA
8.2.1 Company Snapshot
8.2.2 Company Overview
8.2.3 Financial Analysis
8.2.4 Product Benchmarking
8.2.5 Strategic Outlook
8.3 LabCorp
8.3.1 Company Snapshot
8.3.2 Company Overview
8.3.3 Financial Analysis
8.3.4 Product Benchmarking
8.3.5 Strategic Outlook
8.4 Bioskin
8.4.1 Company Snapshot
8.4.2 Company Overview
8.4.3 Financial Analysis
8.4.4 Product Benchmarking
8.4.5 Strategic Outlook
8.5 Javara
8.5.1 Company Snapshot
8.5.2 Company Overview
8.5.3 Financial Analysis
8.5.4 Product Benchmarking
8.6 Proinnovera
8.6.1 Company Snapshot
8.6.2 Company Overview
8.6.3 Financial Analysis
8.6.4 Product Benchmarking
8.6.5 Strategic Outlook
8.7 Innovaderm
8.7.1 Company Snapshot
8.7.2 Company Overview
8.7.3 Financial Analysis
8.7.4 Product Benchmarking
8.7.5 Strategic Outlook
8.8 Biorasi, LLC
8.8.1 Company Snapshot
8.8.2 Company Overview
8.8.3 Financial Analysis
8.8.4 Product Benchmarking
8.8.5 Strategic Outlook
8.9 PAREXEL International Corp
8.9.1 Company Snapshot
8.9.2 Company Overview
8.9.3 Financial Analysis
8.9.4 Product Benchmarking
8.9.5 Strategic Outlook
8.10 Syneos Health, Inc.
8.10.1 Company Snapshot
8.10.2 Company Overview
8.10.3 Financial Analysis
8.10.4 Product Benchmarking
8.10.5 Strategic Outlook

9 Conclusion and Recommendations
9.1 Concluding Remarks from
9.2 Recommendations for Market Players



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 皮膚科向けCRO(医薬品開発業務受託機関)の世界市場2022〜2032(Dermatology CROs Market Report 2022-2032)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆